日本語 
Pharma
Curatis Holding AG has signed an exclusive licensing and development agreement with Japanese pharma company Neupharma for corticorelin, also known as C-PTBE-01. The research examines how to treat peritumoral brain…
Curatis Transfers Corticorelin Japan Rights to Neupharma
Curatis Holding AG has signed an exclusive licensing and development agreement with…
CMIC adopts Bluenote AI to streamline Trial Documentation
CMIC Co., Ltd., a contract research organization jointly owned by Blackstone and…
Hitachi and Shionogi deploy genAI in drug regulatory work
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd.…
Astella and Vir Biotechnology sign global deal for VIR-5500
Astellas Pharma Inc. and Vir Biotechnology, Inc. are teaming up globally to…
Japan Authorizes First iPS Cell-Derived Therapies, Marking Breakthrough in Regenerative Medicine
Japan is at the forefront of healthcare innovation by becoming the first…
Q-Sera Launches RAPClot Blood Collection Tubes in Japan, Marking Breakthrough in Diagnostic Efficiency
Australian diagnostics innovator Q, Sera Pty Ltd has announced that its patented…
Emeraid and Integrity Healthcare finish clinical data project
Emeraid Inc., a healthcare AI DX startup originating from the University of…
B-MAP and Ignis Explore Medical-Skynet AI for Clinics
B-MAP Inc. is pleased to announce that it has today signed a…
English